Figure 2.
Distribution of treatment in patients who progressed after CAR T-cell therapy. Consort diagram illustrates the treatment sequence and distribution of salvage therapy in 38 patients who progressed after CD19 CAR T-cell therapy.
Distribution of treatment in patients who progressed after CAR T-cell therapy. Consort diagram illustrates the treatment sequence and distribution of salvage therapy in 38 patients who progressed after CD19 CAR T-cell therapy.